(Q40061181)

17 September 2017

title

Terminally differentiated neutrophils predominantly express Survivin-2 alpha, a dominant-negative isoform of survivin (English)

1 reference

17 September 2017

Huiyuan Hu

1 reference

17 September 2017

Yayoi Shikama

series ordinal

1 reference

17 September 2017

Isao Matsuoka

series ordinal

1 reference

17 September 2017

Junko Kimura

series ordinal

1 reference

17 September 2017

publication date

26 October 2007

1 reference

Journal of Leukocyte Biology

17 September 2017

published in

1 reference

17 September 2017

1 reference

17 September 2017

1 reference

17 September 2017

page(s)

393-400

1 reference

Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0507282

Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0507282

Cooperative regulation of Mcl-1 by Janus kinase/stat and phosphatidylinositol 3-kinase contribute to granulocyte-macrophage colony-stimulating factor-delayed apoptosis in human neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0507282

Cytokine-mediated Bax deficiency and consequent delayed neutrophil apoptosis: a general mechanism to accumulate effector cells in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0507282

Expression of the inhibitor of apoptosis (IAP) family members in human neutrophils: up-regulation of cIAP2 by granulocyte colony-stimulating factor and overexpression of cIAP2 in chronic neutrophilic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0507282

IAP proteins: blocking the road to death's door

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0507282

A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0507282

Control of apoptosis and mitotic spindle checkpoint by survivin

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0507282

Human survivin is a kinetochore-associated passenger protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0507282

Silencing of survivin gene by small interfering RNAs produces supra-additive growth suppression in combination with 17-allylamino-17-demethoxygeldanamycin in human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0507282

Direct interaction between survivin and Smac/DIABLO is essential for the anti-apoptotic activity of survivin during taxol-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0507282

Survivin study: an update of "what is the next wave"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0507282

Survivin 2alpha: a novel Survivin splice variant expressed in human malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0507282

Role of survivin and its splice variants in tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0507282

Survivin splice variants regulate the balance between proliferation and cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0507282

Differential expression of survivin-2B and survivin-DeltaEx3 is inversely associated with disease relapse and patient survival in non-small-cell lung cancer (NSCLC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0507282

An alternatively spliced survivin variant is positively regulated by p53 and sensitizes leukemia cells to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0507282

Identification of a novel splice variant of the human anti-apoptopsis gene survivin

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0507282

Regulation of the inhibitor-of-apoptosis family member survivin in normal cord blood and bone marrow CD34(+) cells by hematopoietic growth factors: implication of survivin expression in normal hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0507282

Essential role of survivin, an inhibitor of apoptosis protein, in T cell development, maturation, and homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0507282

Dissecting the role of endothelial SURVIVIN DeltaEx3 in angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0507282

Inflammation-associated cell cycle-independent block of apoptosis by survivin in terminally differentiated neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0507282

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0507282

Indole-3-carbinol suppresses NF-kappaB and IkappaBalpha kinase activation, causing inhibition of expression of NF-kappaB-regulated antiapoptotic and metastatic gene products and enhancement of apoptosis in myeloid and leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0507282

Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0507282

21 January 2018

Identifiers

DOI

10.1189/JLB.0507282

1 reference

17 September 2017

1 reference